These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37936598)

  • 1. The Systemic Immune Inflammatory Response Index Can Predict the Clinical Prognosis of Patients with Initially Diagnosed Coronary Artery Disease.
    Li Y; Bai G; Gao Y; Guo Z; Chen X; Liu T; Li G
    J Inflamm Res; 2023; 16():5069-5082. PubMed ID: 37936598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Systemic Inflammation Index Predicts Poor Clinical Prognosis in Patients with Initially Diagnosed Acute Coronary Syndrome Undergoing Primary Coronary Angiography.
    Gao Y; Li Y; Chen X; Wu C; Guo Z; Bai G; Liu T; Li G
    J Inflamm Res; 2023; 16():5205-5219. PubMed ID: 38026253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel Inflammatory Index to Predict Coronary Artery Disease Severity in Patients With Acute Coronary Syndrome.
    Mangalesh S; Dudani S; Mahesh NK
    Angiology; 2024 Mar; 75(3):231-239. PubMed ID: 36629740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Systemic Immune-Inflammation Index with Outcomes in Acute Coronary Syndrome Patients with Chronic Kidney Disease.
    Shi S; Kong S; Ni W; Lu Y; Li J; Huang Y; Chen J; Lin K; Li Y; Ke J; Zhou H
    J Inflamm Res; 2023; 16():1343-1356. PubMed ID: 37006811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate pressure product as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study.
    Jiang ZH; Aierken A; Wu TT; Zheng YY; Ma YT; Xie X
    BMJ Open; 2023 Apr; 13(4):e067951. PubMed ID: 37015792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease.
    Yang YL; Wu CH; Hsu PF; Chen SC; Huang SS; Chan WL; Lin SJ; Chou CY; Chen JW; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB
    Eur J Clin Invest; 2020 May; 50(5):e13230. PubMed ID: 32291748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
    Zhang S; Liu X; Song B; Yu H; Zhang X; Shao Y
    BMJ Open; 2022 Jan; 12(1):e052031. PubMed ID: 35022171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combined Effect of Systemic Immune-Inflammation Index and Type 2 Diabetes Mellitus on the Prognosis of Patients Undergoing Percutaneous Coronary Intervention: A Large-Scale Cohort Study.
    Bian X; He J; Zhang R; Yuan S; Dou K
    J Inflamm Res; 2023; 16():6415-6429. PubMed ID: 38164165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum resistin level and cardiovascular events in postmenopausal women with acute coronary syndrome undergoing percutaneous coronary intervention.
    Li L; Han JL; Mao JM; Guo LJ; Gao W
    Chin Med J (Engl); 2013 Mar; 126(6):1058-62. PubMed ID: 23506578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic immune-inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction.
    Wang Z; Qin Z; Yuan R; Guo J; Xu S; Lv Y; Xu Y; Lu Y; Gao J; Yu F; Tang L; Zhang L; Bai J; Cui X; Zhang J; Tang J
    ESC Heart Fail; 2023 Feb; 10(1):478-491. PubMed ID: 36316302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
    Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao N; Mi L; Liu X; Pan S; Xu J; Xia D; Liu Z; Zhang Y; Xiang Y; Yuan Z; Guan G; Wang J
    PLoS One; 2015; 10(10):e0140532. PubMed ID: 26468876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between White Blood Count to Mean Platelet Volume Ratio and Clinical Outcomes and Severity of Coronary Artery Disease in Patients Undergoing Primary Percutaneous Coronary Intervention.
    Emre AR; Yasar KA; Atakan Y; Orhan C; Murathan K
    Cardiovasc Ther; 2020; 2020():9625181. PubMed ID: 32934665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Incremental Prognostic Value of Pericoronary Adipose Tissue Computed Tomography Attenuation Beyond Coronary Artery Disease Reporting and Data System for Major Adverse Cardiovascular Events in Patients With Acute Chest Pain.
    Wen D; Ren Z; Xue R; An R; Xu J; Li J; Zheng M
    Circ Cardiovasc Imaging; 2023 Jul; 16(7):536-544. PubMed ID: 37381909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Wu TT; Zheng YY; Xiu WJ; Wang WR; Xun YL; Ma YY; Kadir P; Pan Y; Ma YT; Xie X
    Front Cardiovasc Med; 2021; 8():616896. PubMed ID: 34307487
    [No Abstract]   [Full Text] [Related]  

  • 20. The Impact of Subclinical Hyperthyroidism on Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention.
    Yang J; Zheng Y; Li C; Liu Y; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C; Tang YD
    J Clin Endocrinol Metab; 2022 Mar; 107(4):986-997. PubMed ID: 34850030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.